Stay Connected With Us

KYNMOBI

Within up to six weeks after a patient gets diagnosed, no matter how serious or mild PD is, up to 60 percent of those with PD suffer from Off episodes.

‘First and Only’ Sublingual Treatment for Off Episodes in Parkinson’s Disease Gets Approval from FDA

Jun 24, 2020 AM EDT

The US Food and Drug Administration has approved the KYNMOBITM sublingual film for the severe, sporadic treatment of off episodes in individuals who have Parkinson's disease.

Right Now

Healthy Living 5 Benefits of Visiting A Dentist Regularly

5 Benefits of Visiting A Dentist Regularly
Medicine Where Do Unused and Expired Medications Go?

Where Do Unused and Expired Medications Go?
Real Time Analytics